A Top Biotech CEO in Cancer Treatments: F-star Therapeutics CEO Eliot Forster

A Top Biotech CEO in Cancer Treatments: F-star Therapeutics CEO Eliot Forster

Eliot Forster is the Chief Executive Officer of F-star Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing next-generation immunotherapies to transform the lives of patients with cancer. To date, the company has built a comprehensive IP estate, with over 200 issued patents and more than 60 pending applications, many of which have blockbuster potential.

In this conversation, we discuss Eliot’s career as a corporate executive in big pharma as well as his transition to and leadership experience in venture and growth stage biotech. Before coming to F-star in 2018, he served as chief executive officer of Immunocore and prior to that, he held executive positions at Creabilis Therapeutics, Solace Pharmaceuticals, and Pfizer.

We also explore the broader biotech industry in the context of private company investing as well as the specifics of F-star’s drug development programs.

We hope you enjoy the show

Episoder(253)

Scaling Enterprise Software: Sumeru’s Mark Haller

Scaling Enterprise Software: Sumeru’s Mark Haller

In this episode, we speak with Mark Haller, Managing Director and Founding Principal of Sumeru Equity Partners, a technology-focused growth equity firm investing in leading enterprise software compani...

18 Sep 202520min

Mastering Complexity: Transom Capital’s Russ Roenick

Mastering Complexity: Transom Capital’s Russ Roenick

In this episode, we speak with Russ Roenick, Co-Founder and Managing Partner at Transom Capital Group, an operationally focused private equity firm known for thriving in complexity and unlocking value...

11 Sep 202521min

Growth Engineering: Turn/River’s Matt Amico

Growth Engineering: Turn/River’s Matt Amico

In this episode, we speak with Matt Amico, Partner at Turn/River Capital, a lower middle market private equity firm redefining growth with its proprietary growth engineering strategy—built to accelera...

27 Aug 202523min

Focused Growth Equity: Long Ridge’s Kevin Bhatt

Focused Growth Equity: Long Ridge’s Kevin Bhatt

In this episode, we speak with Kevin Bhatt, Managing Partner at Long Ridge Equity Partners, a specialist growth equity firm focused on the financial and business technology sectors.  Kevin joined Long...

13 Aug 202520min

Cybersecurity Gamechanger: Horizon3.ai’s Snehal Antani

Cybersecurity Gamechanger: Horizon3.ai’s Snehal Antani

In this episode, we speak with Snehal Antani, Co-Founder and CEO of Horizon3.ai, a cybersecurity company that delivers autonomous penetration testing through its flagship platform, NodeZero. Designed ...

23 Jul 202525min

AI Infrastructure Builder: Chalk’s Marc Freed-Finnegan

AI Infrastructure Builder: Chalk’s Marc Freed-Finnegan

In this episode, we speak with Marc Freed-Finnegan, Co-Founder and CEO of Chalk, a data platform that powers machine learning and generative AI with real-time, Python-native infrastructure for develop...

16 Jul 202522min

AI Compute Trailblazer: TensorWave’s Piotr Tomasik

AI Compute Trailblazer: TensorWave’s Piotr Tomasik

In this episode, we speak with Piotr Tomasik, Co-Founder and President at TensorWave, a cutting-edge cloud platform purpose-built for AI workloads that delivers high-performance computing with AMD MI3...

9 Jul 202519min

Leading Financial Services Growth Investor: Lee Equity’s Mark Gormley

Leading Financial Services Growth Investor: Lee Equity’s Mark Gormley

In this episode, we speak with Mark Gormley, Partner at Lee Equity Partners, a middle-market private equity firm that partners with entrepreneurs and management teams primarily in the financial and he...

2 Jul 202517min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
pengepodden-2
pengesnakk
tid-er-penger-en-podcast-med-peter-warren
livet-pa-veien-med-jan-erik-larssen
morgenkaffen-med-finansavisen
utbytte
rss-sunn-okonomi
stormkast-med-valebrokk-stordalen
rss-markedspuls-2
okonomiamatorene
lederpodden
liberal-halvtime
finansredaksjonen
rss-finanslunsj